Organizer: WMA GmbH
Registration necessary: yes
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held as a virtual conference from October 2-3, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the Tumor Centre in Munich (TZM),the Society for Immunotherapy of Cancer (SITC) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
More information can be accessed on this webpage.
Registration can be done on this webpage.
Due to the spread of coronavirus (COVID-19), the conference was postponed from April 2-4, 2020 to October 2-3, 2020 and will be held as a virtual conference.
To see the program, please click here.